Literature DB >> 29336543

Histone Deacetylase 11 Is a Fatty-Acid Deacylase.

Zsofia Kutil1, Zora Novakova1, Marat Meleshin2, Jana Mikesova1, Mike Schutkowski2, Cyril Barinka1.   

Abstract

Histone deacetylase 11 (HDAC11) is a sole member of the class IV HDAC subfamily with negligible intrinsic deacetylation activity. Here, we report in vitro profiling of HDAC11 deacylase activities, and our data unequivocally show that the enzyme efficiently removes acyl moieties spanning 8-18 carbons from the side chain nitrogen of the lysine residue of a peptidic substrate. Additionally, N-linked lipoic acid and biotin are removed by the enzyme, although with lower efficacy. Catalytic efficiencies toward dodecanoylated and myristoylated peptides were 77 700 and 149 000 M-1 s-1, respectively, making HDAC11 the most proficient fatty-acid deacylase of the HDAC family. Interestingly, HDAC11 is strongly inhibited by free myristic, palmitic, and stearic acids with inhibition constants of 6.5, 0.9, and 1.6 μM, respectively. At the same time, its deacylase activity is stimulated more than 2.5-fold by both palmitoyl-coenzyme A and myristoyl-coenzyme A, pointing toward metabolic control of the enzymatic activity by fatty-acid metabolites. Our data reveal novel enzymatic activity of HDAC11 that can, in turn, facilitate the uncovering of additional biological functions of the enzyme as well as the design of isoform-specific HDAC inhibitors.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29336543     DOI: 10.1021/acschembio.7b00942

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  34 in total

1.  Activity-Guided Design of HDAC11-Specific Inhibitors.

Authors:  Se In Son; Ji Cao; Cheng-Liang Zhu; Seth P Miller; Hening Lin
Journal:  ACS Chem Biol       Date:  2019-07-02       Impact factor: 5.100

Review 2.  Structure, mechanism, and inhibition of the zinc-dependent histone deacetylases.

Authors:  Nicholas J Porter; David W Christianson
Journal:  Curr Opin Struct Biol       Date:  2019-02-08       Impact factor: 6.809

3.  Entropy as a Driver of Selectivity for Inhibitor Binding to Histone Deacetylase 6.

Authors:  Nicholas J Porter; Florence F Wagner; David W Christianson
Journal:  Biochemistry       Date:  2018-05-18       Impact factor: 3.162

4.  Garcinol Is an HDAC11 Inhibitor.

Authors:  Se In Son; Dan Su; Thanh Tu Ho; Hening Lin
Journal:  ACS Chem Biol       Date:  2020-10-09       Impact factor: 5.100

5.  [Overexpression of histone deacetylase 11 suppresses basal-like breast cancer cell invasion and metastasis].

Authors:  Zhang Yi; Luo Wenwen; Wang Kun; Shi Jian
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-07-30

Review 6.  Polyamine Deacetylase Structure and Catalysis: Prokaryotic Acetylpolyamine Amidohydrolase and Eukaryotic HDAC10.

Authors:  Stephen A Shinsky; David W Christianson
Journal:  Biochemistry       Date:  2018-03-21       Impact factor: 3.162

7.  A Click Chemistry Approach Reveals the Chromatin-Dependent Histone H3K36 Deacylase Nature of SIRT7.

Authors:  Wesley Wei Wang; Maria Angulo-Ibanez; Jie Lyu; Yadagiri Kurra; Zhen Tong; Bo Wu; Ling Zhang; Vangmayee Sharma; Jennifer Zhou; Hening Lin; Yi Qin Gao; Wei Li; Katrin F Chua; Wenshe Ray Liu
Journal:  J Am Chem Soc       Date:  2019-02-04       Impact factor: 15.419

8.  Design, synthesis and biological evaluation of β-peptoid-capped HDAC inhibitors with anti-neuroblastoma and anti-glioblastoma activity.

Authors:  Nina Reßing; Viktoria Marquardt; Christoph G W Gertzen; Andrea Schöler; Alexander Schramm; Thomas Kurz; Holger Gohlke; Achim Aigner; Marc Remke; Finn K Hansen
Journal:  Medchemcomm       Date:  2018-10-23       Impact factor: 3.597

Review 9.  Structural determinants of affinity and selectivity in the binding of inhibitors to histone deacetylase 6.

Authors:  Jeremy D Osko; David W Christianson
Journal:  Bioorg Med Chem Lett       Date:  2020-02-11       Impact factor: 2.823

10.  Critical review of non-histone human substrates of metal-dependent lysine deacetylases.

Authors:  Tasha B Toro; Terry J Watt
Journal:  FASEB J       Date:  2020-08-30       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.